1/x 🧵Thank you to @bmj_latest for an excellent article doi.org/10.1136/bmj.o2… by @Garethiacobucci "Evusheld: Government is urged to expedite covid antibody treatment for vulnerable patients". It highlights ongoing clinical pressure to protect the #immunocompromised. Pls RT Image
2/x What's the issue......"With covid-19 cases rising 📈 and winter approaching, immunocompromised patients are frustrated at the government’s 🏦 inaction on rolling out the preventive drug" 💉 Image
3/x "The UK government has been urged to re-examine its decision not to purchase a new covid-19 antibody drug for clinically extremely vulnerable people, amid warnings that these patients face renewed risk from the disease this winter."😢 Image
4/x "Evusheld was approved for use in the UK in March 2022 by the Medicines and Regularly Healthcare Products Agency after trial results showed that it reduced the risk of developing symptomatic covid-19 by 77%, with protection lasting at least six months after a single dose." Image
5/x "Evusheld is submitted for approval by the National Institute of Health and Care Excellence. But, because this process is not due to conclude until well into 2023, clinicians & patients have warned that people who could potentially benefit will miss out this winter." Image
6/x What's my take? Well, there are inconsistency between the government’s policy on covid vaccines and its approach to antibody treatments. The window 🪟 for protecting very vulnerable patents this winter was rapidly closing...
7/x Why does this matter? There are half a million immunocompromised people in the UK. Many are still shielding, still in isolation, still unable to work, see friends or hug loved ones. They are #forgotten500k, unheard and calling on us to notice.
8/x Thanks to patients, clinicians @AlexRichter3 @ProfBMT, the clinical community has also sprung into action. Patients, 125 clinicians from 17 medical specialities & 4 nations are united in asking for action and potentially the missing decision maker.
9/x Thanks to @libdemdaisy, there is now a parliamentary debate on 12th of October at 11am. whatson.parliament.uk/event/cal39847. We hear MPs are being swamped by emails from patients and their doctors asking for action on to protect the immunocompromised
10/x And in a unusual twist, patient groups and their 19 charities are now asking relatives, grandchildren and grandparents to sit in parliament square on their behalf. The aim is to get DHSC civil servants to notice them and give them protection. I've not seen patient power like Image
11/x this before. UK patients wish to have the same protection as available in France, US and 32 other countries. There are half a million immunocompromised people in the UK. Many are still shielding, still in isolation, still unable to work, see friends or hug loved ones 😢 Image
12/x They #forgotten500k unheard & calling on us to notice. So many people left behind. From the comments 👇- patients/clinicians are grateful for people like @Garethiacobucci for going the extra mile to share the story & plight for protection +🤞 for a good outcome before xmas. Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Dr Lennard Lee (Oxford University)

Dr Lennard Lee (Oxford University) Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @drlennardlee

Sep 29
1/x ***New Research***. 🧵Relevant to the #immunocompromised with @bloodcancer_uk + #forgotten500k campaign. By a trusted lab in New York- Greenberger lab. Looking at immune responses to COVID vaccination. It is my new fav journal due to their colours! aacrjournals.org/bloodcancerdis…
2/x. It was done as many blood cancer🩸patients have no detectable immune response following coronavirus vaccination 💉. It is accepted that if you don’t respond to a vaccination, you aren’t as well protected from COVID-19. This answers the counter-argument- is this okay?
3/x. In 505 patients with B-cell malignancies, in a real world setting. This is a new form of study scientists use nowadays (vs a randomised study-RCT, where 50% of people get a sugar injection). RCT are generally not thought to be acceptable. They looked at patient's blood.
Read 17 tweets
Sep 27
1/x 🧵I was humbled by #immunocompromised patients for a surprise gift as we try to "surface" the #forgotten500k issue. Nice surprise before my busy NHS clinic. Our clinical leads didn't plan to be here and are glad to support the coronavirus Winter plan/pilot call #evusheld.
2/x I believe that calls for action/help from patient groups + charities are important + need acknowledgement. If people are in difficult positions, still shielding after 2.5 years 😢🏠, the best we can do is try & carefully evaluate. I am glad they trust us/me to speak for them.
3/x. Thanks as ever to the @APPG_VGP for starting this patient action campaign. I don't know if we will get their pilot by Winter, for some patients to benefit, but if they do, I know they can count on our doctors and the 125 across 17 specialities to support!😀
Read 4 tweets
Sep 23
1/x 🧵What happens when a diverse group of patients at risk from COVID-19 try to ask what they need? In this case, #immunocompromised & their small ask for protection from COVID-19 with #evusheld. This is my honest assessment as a UK NHS doctor. 👨‍⚕️🏥. Pls RT.
2/x What's the background? In this case the group affected from COVID-19 are both young + old. They are #immunocompromised. They may have cancer, blood cancer, transplant, autoimmune disease or immunosuppressants. A patient group hasn't linked them before. 🧑‍💻👩‍⚖️👨‍🍳👨‍🌾
3/x. The pandemic brought them together, because many of them were checking if they had an immune response to coronavirus vaccine, the best form of protection from COVID-19 and they found they had low/absent immune responses. 🙄. itv.com/news/2022-08-1…
Read 25 tweets
Sep 21
1/x 🧵This is an important issue that many clinicians are worried about & I am glad to have been put forwards to talk on behalf of the @APPG_VGP, its 19 patient charities and the National Clinical Expert group which pulls representation from 17 medical specialities & 4 nations...
2/x What's the background? We are living with coronavirus and most of us have high levels of protection from our vaccination 👍😃. However, not everyone gets high levels of protection. If you have a weakened immune response, your protection may not be as quite as high....
3/x. People with a weakened immune response are #immunocompromised & it can affect the young and old. It can happen because you have a cancer or blood cancer, a transplant, an autoimmune condition or because of drugs you receive from your doctor. 🧑‍⚕️💊😷. There are 500,000 people.
Read 18 tweets
Sep 3
1/x. 🧵With HEALTH policy, there should be transparency + solid evidence that standard process was followed. RACI- RESPONSIBILITY 📝 1️⃣who made decisions, 2️⃣who was the clinical teams advising 3️⃣who was providing scientific input. ACCOUNTABILITY 🎖. With a decision of this
2/x magnitude affecting so many #immunocompromised people, normally very eminent & respected medical physicians would have been involved 👨🏼‍⚕️👩🏽‍⚕️🧑🏻‍⚕️. CONSULTATION🎪- stakeholder dialogue across 4 nations, across the specialities 🏥treating these groups
3/x. Finally INFORMED GROUPS🧑🏻. They are normally key 🔑 and informed as part of the process. For participation and to minimise potential distress. 🙁. They need to understand the nuances why and why not and that decisions were not “predecided”. It had to be “fair” at the time.
Read 9 tweets
Aug 31
1/x ***New data 🧵 *** Landmarker paper from France- @Timothee_B from the Pasteur institute in France. Brilliant article for #immunocompromised (#Evusheld). A fascinating science study about how long you are protected for. medrxiv.org/content/10.110…
2/x What's the background? With winter coming and the high transmissibility of omicron, across the Northern hemisphere, countries are moving to protect their immunocompromised. These are people who may have lower levels of protection from vaccination.
3/x This paper looked at 6 antibodies against variants -Delta, BA2, BA.4 and BA.5 isolates. This was important as vaccines provide lower levels of protection against these variants, & it was unclear if antibodies maintain or lose protection too. ❓❓❓
Read 14 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(